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Abstract
Objectives To establish the recovery priorities of individuals
suffering with degenerative cervical myelopathy (DCM).
Design A cross-sectional, observational study.
Setting Patients from across the world with a diagnosis
of DCM accessed the survey over an 18-month period on 
Myelopathy.org, an international myelopathy charity.
Participants 481 individuals suffering from DCM
completed the online survey fully.
Main outcome measures Functional recovery domains
were established through qualitative interviews and a
consensus process. Individuals were asked about their
disease characteristics, including limb pain (Visual
Analogue Scale) and functional disability (patient-derived
version of the modified Japanese Orthopaedic Association
score). Individuals ranked recovery domains (arm and
hand function, walking, upper body/trunk function, sexual
function, elimination of pain, sensation and bladder/bowel
function) in order of priority. Priorities were analysed as
the modal first priority and mean ranking. The influence of
demographics on selection was analysed, with significance
p<0.05.
Results Of 659 survey responses obtained, 481 were
complete. Overall, pain was the most popular recovery
priority (39.9%) of respondents, followed by walking
(20.2%), sensation (11.9%) and arm and hand function
(11.5%). Sexual function (5.7%), bladder and bowel (3.7%)
and trunk function (3.5%) were chosen less frequently.
When considering the average ranking of symptoms,
while pain remained the priority (2.6±2.0), this was
closely followed by walking (2.9±1.7) and arm/hand
function (3.0±1.4). Sensation ranked lower (4.3±2.1). With
respect to disease characteristics, overall pain remained
the recovery priority, with the exception of patients with
greater walking impairment (p<0.005) who prioritised
walking, even among patients with lower pain scores.
Conclusions This is the first study investigating patient
priorities in DCM. The patient priorities reported provide an
important framework for future research and will help to
ensure that it is aligned with patient needs.

Introduction
Degenerative cervical myelopathy (DCM)
has been coined as an umbrella term for

Strengths and limitations of this study
►► This is the largest study of patient perspective in de-

generative cervical myelopathy (DCM) to date and
the first to consider patient recovery priorities.
►► This study is unique in reporting on both surgical
and non-surgical DCM patients.
►► This study includes a broad demographic representation of patients from across the globe and includes
subgroup analysis.
►► This is an open-access, internet-based survey, a
methodology which can lead to a sampling bias.
►► Efforts to mitigate against sampling bias, alongside
reassuring subgroup analysis suggest this risk is
low.

degenerative and congenital or acquired
conditions of the cervical spine, such as spondylosis or ossification of the posterior longitudinal ligament, which lead to symptomatic
cord compression.1 With an estimated prevalence of up to 5% in individuals above 40
years old,2 3 DCM is the most common cause
of spinal cord dysfunction worldwide.1 Given
its degenerative aetiology and the rising age
of the population, this incidence is expected
to rise.4
The cervical spinal cord acts as a processor
and conduit of information between the brain
and the periphery. Its injury can, therefore,
give rise to a range of possible symptoms.1
These include pain, paraesthesia, weakness,
unsteadiness, frequent falls, bladder or bowel
dysfunction and impotence in men.5 At early
stages, individual symptoms may occur in
isolation, but more typically occur in combination, especially as the disease advances.
At present, decompressive surgery is the
only evidence-based treatment for DCM.6
Surgical decompression is able to halt the
progression of symptoms and offer limited,
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although clinically-relevant7 improvements across a
range of domains.8 9 However, due to the limited intrinsic
capacity for the spinal cord to repair, most patients do not
make a full recovery, and instead suffer lifelong disabilities.9 As a consequence, unemployment and/or dependency is prevalent among individuals with DCM.4 10 11
Moreover, a recent study has identified that DCM severely
impacts quality of life with recorded 36-Item Short Form
Health Survey (SF-36), patient-reported outcome scores
among the lowest of all chronic disease.12 Improving
recovery is, therefore, a major unmet clinical need in
DCM.13
Medical research is primarily designed by healthcare
professionals. This bears the risk of not taking into
account actual patient needs. The concept of ‘research
wastage’ has emerged to depict healthcare research that
does not yield actual or potential clinical benefit. In
the 2014 Lancet series, Chalmers et al estimated that as
much as 85% of the US$240 billion expended on health
research in 2010 was wasted and an important contributing factor was the misalignment of patient and clinician research objectives.14 15 As a consequence, several
research funding bodies now advocate the involvement
of patients in the design and conduct of research. This
has demonstrable beneficial impact.16 Patient and public
involvement (PPI) plays a particularly important role in
the National Institute for Health Research.17 In addition to participation and engagement in the research
process, the involvement of patients in identifying relevant research topics and their prioritisation is particularly encouraged. Organisations, such as the James Lind
Alliance, have successfully brought together patients,
professionals and industry in order to set research priorities, for example, for spinal cord injury.18 However, the
research priorities for individuals suffering from DCM
have not yet been assessed.
A recent systematic review of DCM research demonstrated a heavy focus on surgical technique.19 20 However,
the research needs of patients with DCM and their priorities remain unknown. Moreover, as part of a core-outcomes initiative REsearch Objectives and COmmon
Date Elements in DCM, we have identified that outcome
domains are not consistently reported in current clinical
research.19
In this study, we sought to establish the recovery needs
and priorities of individuals suffering from DCM. This
will help to determine the outcome assessments that
should be included in clinical research and to better
direct future research.

Methods
Reporting adheres to the Enhancing the QUAlity and
Transparency Of health Research (EQUATOR) Network
Strengthening the Reporting of Observational Studies in
Epidemiologychecklist.21
2

Survey design
Individuals with DCM and their caregivers were invited to
attend the M
 yelopathy.org PPI day, hosted at the University of Cambridge and captured by Cambridge TV in their
documentary.22 Myelopathy.org is an international, charitable organisation for individuals affected by or working
with DCM. As part of the event, qualitative interviews
(n=9) were used to establish relevant functional domains
that affected quality of life of individuals with DCM. These
were found to resemble domains previously reported by
Anderson et al, who conducted a survey among patients
with traumatic spinal cord injury asking them to rank
seven domains of spinal cord function in order of priority
for recovery.23 Using this as a template but broadening
upper body/trunk strength and balance’ to upper body/
trunk function, the following recovery domains were
agreed by the participants: elimination of pain, arm and
hand function, walking, sexual function, upper body/
trunk function, sensation and bladder/bowel function.
For brevity, in this article, they are referred to as arm/
hand, walking, sexual function, pain, sensation, trunk
and bladder/bowel.
These questions were embedded into an existing electronic survey initiative, developed using Survey Monkey
(California, USA) and following the Checklist for
Reporting Results of Internet E-Surveys,24 investigating
patient reporting of DCM. This iteration was piloted by
the lead investigators and a selection of individuals with
DCM. Study objectives were outlined on the initial page,
including details of the host organisation and estimated
time required to complete the survey. This acted as the
electronic consent, with continuation into the survey
as agreement. Respondents were also presented with a
description of DCM, including relevant synonyms, and
required to confirm they suffered with the condition.
Respondents were asked to rank recovery domains in
order of priority and provide details about their DCM.
DCM characteristics included age, gender, history of
surgery, best daily limb pain score (using a Visual Analogue
Scale), duration of symptoms and disease severity as
measured using the self-reported, patient-derived, modified Japanese Orthopaedic Association (P-mJOA).25 The
mJOA is among the most commonly used assessments of
disease severity19 20 and is fully- validated.26 It is a composite
score based on upper limb function, lower limb function,
upper limb sensation and bladder function. The score is
valid for analysis in its entirety or per domain. Originally
developed as an investigator-administered tool, it has
recently been adapted and validated for use by patients.25
All questions were mandatory, but respondents were not
required to rank every recovery domain, on the basis
that some domains may not be a priority for them. The
sequence of questions and order of responses was not
altered from respondent to respondent.
Survey administration
The survey was accessed via a landing page on M
 yelopathy.
org, allowing assessment of response rates using Google
Davies B, et al. BMJ Open 2019;9:e031486. doi:10.1136/bmjopen-2019-031486
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Analytics (California, USA). Individuals with DCM were
recruited over an 18-month period. The recruitment
process has been described in detail previously27 but in
short, the survey was advertised using Google Adwords
(California, USA) and through M
 yelopathy.
org and
its social media outlets. The survey was voluntary and
internet protocol addresses were used to prevent users
submitting multiple responses. A missing data analysis
was conducted between complete and incomplete survey
responses to consider if particular subgroups were more
likely to terminate early. Complete responders were
defined as having provided answers for all aforementioned variables.
Analysis
Research priorities are presented using summary statistics, including average ranking and overall proportion
of patients per domain. Domains that were not ranked
by a respondent were omitted from these scores. For
subgroup analysis, variables were dichotomised and
thresholds were chosen based on the graphical distribution of responses and sample sizes. Categorical variables
were compared using the χ2 test. For continuous variables, the Shapiro-Wilk test was used to assess for parametric distribution of data sets. The Mann-Whitney U test
was then used to compare the means of non-parametric
distributions while a two-tailed t-test used to compare the
means of parametric distributions. Pearson’s correlations
were performed to assess between-group differences in
characteristics, which could have influenced subgroup
analysis. Significance was set at p<0.05.
Patient and public Involvement
Patients were involved in the design, development, recruitment and conduct of this study. At a PPI day hosted at the
University of Cambridge, a focus group of DCM patients
evaluated and confirmed the recovery domains in DCM.
DCM patients were used to pilot the subsequent survey,
including optimising its design to reduce the time taken
to complete and clarify questions. The online survey for
the study was hosted on M
 yelopathy.org, an international
DCM charity run largely by DCM patients. Patients were,
therefore, active in disseminating the survey via online
DCM support groups, including Myelopathy Support, led
by IS, patient and coauthor. Patients who were involved
in preparation of the manuscript are among the authors.
In addition, all patients who participated in the research
are recognised in the acknowledgement statement. DCM
patients are involved in plans to disseminate this research
to the patient community, including blog articles on
Myelopathy.org, posts in online patient support groups
and presence at spinal conferences in the UK.

Results
Respondents
The survey was uniquely accessed 1463 times, with 659
visitors entering the survey (participation rate of 45%). A
Davies B, et al. BMJ Open 2019;9:e031486. doi:10.1136/bmjopen-2019-031486

Table 1 Summary of respondent demographics
Respondent demographics
Age (Mean±SD)
Male gender (%)

53.6 (9.8)
140 (29)

Undergone surgery (%)

221 (46)

Length of symptoms (%)
 0–1 year

72 (15)

 1–3 years

140 (29)

 3–10 years

181 (38)

 10–25 years

74 (15)

 25+years

14 (3)

P-mJOA (Mean+SD)
 Upper limb function

3.6 (1.0)

 Walking

4.4 (1.5)

 Upper limb sensation

1.7 (0.7)

 Bladder function

2.2 (1.0)

 Total
 VAS limb pain (Mean±SD)

11.9 (3.0)
3.1 (2.6)

P-mJOA, patient-derived version of the modified Japanese
Orthopaedic Association; VAS, Visual Analogue Scale.

total of 481 responses contained complete data (completion rate 73%). A missing data analysis was conducted
comparing incomplete and complete responses. Patients
who completed the survey in full were more likely to
have undergone surgery (p=0.04), otherwise there was
no statistical difference within variables of interest (see
online supplementary data 1). Only complete responses
were analysed in the present study. Of these responsesdomains were ranked more than 80% of the time: pain
(400, 83%), sensation (428, 89%), walking (396, 82%),
arm and hand (393, 82%), sexual (388, 81%), bladder
and bowel (399, 83%) and trunk function (407, 85%).
On average, respondents were more likely to be
female (341, 71%) and suffer with moderate myelopathy
(11.9±3.0) for between 3 and 10 years (181, 38%). Around
half of patients (221, 46%) had undergone surgery.
Overall respondent demographics are summarised in
table 1. Considering group differences, patients who
had suffered from the disease for longer appeared more
likely to have undergone surgery (p=0.07) and have worse
myelopathy (r=−0.22, p<0.005). They were also more
likely to suffer greater pain (r=−0.14, p<0.01). Average
pain scores were 3.1 (±2.4) for patients suffering with the
disease for less than a year, rising to 4.5 (±3.0) for patients
suffering for at least 10 years. There was no relationship
between severity of myelopathy and pain scores (r=−0.04,
p=0.36). Between-group differences are summarised in
online supplementary data 2.
Ranking of spinal cord dysfunction domains
Overall, pain was the most popular number one ranked
recovery domain, chosen by 39.9% of respondents. This
3
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Figure 1 Overall recovery priorities. The bar chart represents the first choice of patients and the line graph the average
ranking for each domain (where the top ranking is 1). Pain was the overall first choice priority of patients, although when priority
rankings were averaged, this was closely followed by walking and arm/hand function.

was followed by walking (20.2%), sensation (11.9%) and
arm and hand function (11.5%). Sexual function (5.7%),
bladder and bowel (3.7%) or trunk function (3.5%) were
chosen less frequently. When considering the average
ranking of symptoms, while pain remained the priority
(2.6±2.0), this was closely followed by walking (2.9±1.7)
and arm/hand function (3.0±1.4) (figure 1). Sensation
ranked lower (4.3±2.1).
Impact of baseline characteristics on ranking of spinal cord
dysfunction domains
Respondents who had undergone surgery were more
likely to prioritise walking (p<0.005) and trunk function
(p=0.03), whereas patients who had not yet undergone
surgery were more likely to prioritise upper limb function (p<0.05) (figure 2). Patients with poor upper limb or
lower limb function were more likely to prioritise arm/
hand recovery (p<0.005) and walking (p<0.005), respectively (figure 2). Overall, pain remained the priority,
with the exception of patients with the greatest walking
impairment (p<0.005), even among patients with lower
pain scores (figure 2).
When considering the average rankings pain, arm/hand
function and walking remained the top three recovery
priorities (figure 3). However, among the subcategories, the
order of these priorities differed slightly (see online supplementary data 3). Patients who were male, or who had undergone surgery, or who had greater upper limb, lower limb or
bladder functional disability, prioritised recovery of walking,
over pain and arm/hand function; patients with greater
sensory disability prioritised recovery of arm/hand function
over pain and walking.
When overall P-mJOA scores were considered to evaluate mild, moderate and severe patients,6 no variation
was seen in modal or average ranked priorities.
4

Discussion
This is the first study to systematically survey functional
domains relevant to DCM and to ask patients to rank
them in order of importance to their quality of life. The
established priorities are likely to reflect symptom prevalence and their impact on day-to-day life.23 The analysis
of 481 completed answers demonstrated that pain, arm/
hand function and walking emerge as the most important
spinal cord dysfunction domains. Although based on
averaged rankings, there were some subtle differences
in ordering of these three domains. With the exception
of patients with significant gait impairment, elimination
of pain was the recovery priority independent of baseline
characteristics.
These findings are surprising: functional disability
(specifically recovery of arm/hand and walking
function) has been and continues to be a focus for
researchers, typically in response to surgery,8 but more
recently with a shift towards enhancing postsurgical
recovery.13 27 In contrast, pain is not widely recognised
as an important relevant domain. Our recent review
of outcome reporting in DCM clinical trials demonstrated that the overwhelming majority of studies (90%)
reported outcomes related to function, but only 27%
of studies reported outcomes related to pain,19 despite
the fact that pain is a well-recognised feature of DCM,5
which often improves following surgery.11 The present
findings highlight the fact that systematic research
of patient needs is sorely lacking in DCM. A possible
explanation for this discrepancy is that surgeons, who
play a significant role in the management of DCM and
predominate this research field, remain biased towards
functional domains because pain is not a recognised
indication for surgery in DCM.6
Davies B, et al. BMJ Open 2019;9:e031486. doi:10.1136/bmjopen-2019-031486
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Figure 2 Impact of baseline characteristics on first choice recovery priority. The bar chart represents the first choice of
patients. Significant between-group differences are denoted by the * symbol. For simplicity, groups were dichotomised as
follows: (A) duration of symptoms≤3 years, (B) male or female, (C) surgery or pre-surgery, (D) P-mJOA upper limb function≤2,
(E) P-mJOA lower limb function≤3, (F) mJOA upper limb sensation≤1, (G) VAS limb pain≤3 and (H) P-mJOA bladder/bowel
function≤1 . Those who had undergone surgery were more likely to choose trunk function (p=0.03) or walking function
(p<0.005), whereas those who had not yet undergone surgery were more likely to choose arm/hand function (p<0.05). Equally
patients with more impairment of walking (p<0.005) or arm/hand function (p<0.005) were more likely to prioritise these domains.
Pain remained the priority even in patients reporting less pain. P-mJOA, patient-derived version of the modified Japanese
Orthopaedic Association; VAS, Visual Analogue Scale.

The priorities established in the present study differ
from those of individuals suffering from spinal cord
injury. Although pain is among the most prevalent symptoms of traumatic spinal cord injury,28 29 the ‘elimination
of chronic pain’ was considered to be a relatively low
priority among those surveyed in Anderson’s study23 and
a similar study by Kwon et al,30 that focused on the priorities for SCI recovery after novel treatments (eg, stem
cells). Instead, quadriplegics prioritised arm/hand function, while paraplegics sexual and bladder/bowel function. These differences relate to their specific significance
for patient independence and quality of life.
In DCM, the symptom burden is less well-described31 32
and the relationship between symptom burden or significance with respect to quality of life in DCM has not been
investigated. However, it would seem likely a similar relationship exists.
Limitations
Following recommendation by the James Lind Alliance, which was founded to support priority setting in
research,33 34 the present survey was conducted online,
as previously described, through a DCM charity, Myelopathy.org.27 Respondents belonged to a self-selecting
group of individuals who were asked to confirm they had
been diagnosed with DCM by a medical professional,
after being presented with a description of the disease
Davies B, et al. BMJ Open 2019;9:e031486. doi:10.1136/bmjopen-2019-031486

for verification purposes. It is possible that some respondents did not have DCM. Reassuringly, respondent demographics were comparable to those of leading prospective
surgical studies, with the exception of gender, which was
not shown to influence patient priorities8 9 (see online
supplementary data 1). This likely reflects the recognised
popularity of online health communities among females.
There are no such comparable series for non-surgical
cohorts, but their inclusion provides a further valuable
perspective.
The survey questions were not randomly sorted and
therefore each respondent answered identical surveys
with spinal cord function domains presented in the same
order. The last domain assessed was sensation. In keeping
with it being the most prevalent DCM symptom,32 it
featured most frequently in the responses, indicating that
the order of domains was unlikely to have influenced the
rankings. Moreover, answers to demographic questions,
which followed the ranking of priorities in the survey,
were required to define a complete response in order to
be included in the present analysis. Priorities, therefore,
were not influenced by incomplete answers.
Following the qualitative development work and the
previous experience of Anderson et al, the pain domain
was kept non-specific, asking patients to rank ‘elimination
of pain’ as a recovery priority (see online supplementary
5

Open access

Figure 3 Impact of baseline characteristics on recovery priority average rankings. The scatter plot represents the mean
ranking for each subgroup investigated. The blue line represents the overall average. Despite some discrepancies between
subgroups, pain, arm/hand and walking function were consistently the top three priorities for patients. Bladder/bowel function
was not a recovery priority. P-mJOA, patient-derived version of the modified Japanese Orthopaedic Association; VAS, Visual
Analogue Scale.

data 4). In contrast, however, the pain assessment focused
on limb pain, which is classically felt to represent DCM-related pain.5 While this does not limit the implications of
our findings as whole, their interpretation will require a
better characterisation of pain in DCM in order to focus
research appropriately as other pain foci are reported.35

Conclusion
The priorities reported in the present study identify functional domains that are relevant to the quality of life of
DCM patients. They provide an important framework for
future research and will serve as a valuable reference for
the development of a core outcome set relevant to studies
in DCM.
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